Company Overview - Shangrong Medical's closing price on August 22 was 4.63 yuan, down 1.07%, with a rolling PE ratio of 175.05 times and a total market value of 3.915 billion yuan [1] - The company operates in the medical device industry, which has an average PE ratio of 56.95 times and a median of 40.49 times, placing Shangrong Medical at the 112th position in industry rankings [1][2] - As of March 31, 2025, the number of shareholders was 58,323, a decrease of 621 from the previous count, with an average holding value of 352,800 yuan and an average holding of 27,600 shares per shareholder [1] Business Operations - Shangrong Medical specializes in the production and sales of medical products, medical services, and health industry operations [1] - The company is recognized as one of the earliest to introduce clean technology into hospital operating rooms in China [1] - Its intelligent self-controlled operating room products have received multiple national honors, including recognition from the Ministry of Science and Technology and the Shenzhen Municipal Government [1] Patent and Innovation - The company and its subsidiaries have obtained over 180 patents, which serve as a driving force for its continuous development [1] Financial Performance - In the first quarter of 2025, Shangrong Medical reported an operating income of 280 million yuan, a year-on-year increase of 1.30%, and a net profit of 13.9642 million yuan, reflecting a year-on-year growth of 0.58% [2] - The sales gross margin for the same period was 15.27% [2]
尚荣医疗收盘下跌1.07%,滚动市盈率175.05倍,总市值39.15亿元